Corvus Pharmaceuticals, Inc. — Director's Dealing 2025

May 9, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2025-05-07

Reporting Person: MILLER RICHARD A MD (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-07	Common Stock	M	559073	$3.5	Acquired	1136707	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-07	Warrant (Right to Buy)	$3.5	M	559073	Disposed	2025-06-30	Common Stock (559073)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1188103	Indirect

Footnotes

F1: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.

F2: Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.